Meridiem Capital Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Buy
451,493
+134,543
+42% +$2.93M 0.58% 66
2026
Q1
$5.5M Buy
+316,950
New +$6M 0.36% 61
2025
Q3
Sell
-123,390
Closed -$2.41M 75
2025
Q2
$2.41M Buy
+123,390
New +$2.19M 0.17% 68

Other funds holding CDNA

Meridiem Capital Partners's CDNA Position: Q2 2026 in Review

Meridiem Capital Partners increased its CareDx (CDNA) stake by 42% in Q2 2026, buying an estimated $2.93M and bringing the position to 451,493 shares worth $12.9M. The position accounts for 0.58% of the portfolio, ranked #66.

Meridiem Capital Partners first reported a position in CDNA in Q2 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Meridiem Capital Partners held 451,493 shares of CareDx worth $12.9M as of Q2 2026.
  • Meridiem Capital Partners bought 134,543 CareDx shares in Q2 2026, an estimated $2.93M.
  • CareDx made up 0.58% of Meridiem Capital Partners's portfolio in Q2 2026, its #66 holding.
  • Meridiem Capital Partners first reported a position in CareDx in Q2 2025 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.